Thierry Aupérin
Vice President, Global Scientific Communications
Alnylam Pharmaceuticals
Education
PhD, Biophysics and Pharmacology
Bio
I joined Alnylam in 2019 in the Global Medical Affairs organization. I oversee all scientific communications and educational activities for research and development at Alnylam.
With 20+ years of pharmaceutical industry experience, I have a wealth of medical and operational expertise and building and leading successful teams. I have dedicated my career to supporting the education of the healthcare community. I started as a Medical Science Liaison, and have held various positions with increasing leadership responsibilities, supporting US and global organizations, leading scientific and medical communications and publications, as well as building medical affairs organizations and capabilities. I have worked at several organizations, from large pharmaceutical companies to small startups, with most of my career being within mid-sized biotech at Vertex, Biogen, Bioverativ, and now Alnylam.
I received a Bachelor of Science (cum laude) in Marine Biology & Biochemistry from the University Pierre et Marie Curie, Paris, France, and mt PhD (summa cum laude) in Biophysics & Pharmacology from the University of Pharmacy, Montpellier, France in collaboration with Harvard Medical School, Boston.
I enjoy spending time with my two daughters, cooking, and am also an avid cyclist, participating in many fundraising races to support the MS society and the Pan-Mass Challenge among other important causes.
What drew you to serve with JEI on its Board of Directors?
By being on the board of the Journal of Emerging Investigators, I hope to help cultivate both the technical and communication skills necessary for young researchers to thrive, reinforce their appetite for science, and develop critical analytical skills to foster their career. I’m excited to contribute to a platform that supports their development early on, enabling them to share their discoveries with clarity and confidence.